The relationship between atopy and non-specific bronchial responsiveness.
Atopy is often regarded as a risk factor for the development of asthma, particularly childhood asthma and occupational asthma. This could reflect an association with non-specific bronchial responsiveness (NSBR), though atopy could influence asthma independently. We have evaluated the possible relationship between atopy and NSBR (PD20FEV1 to methacholine) in the siblings of 59 probands with atopic asthma. Thirty-four (58%) were atopic (greater than or equal to 1 prick test with weal diameter greater than or equal to that of a 0.1% histamine control) and 28 (47%) showed NSBR. Atopy and NSBR occurred together more frequently than would be expected by chance (P less than 0.05); both variables being observed in 20 subjects, neither in 17, and only one in 22. A significant association was also noted when atopy was defined by a serum total IgE greater than 150 IU (or greater than 50 IU), but when atopy was defined by other commonly used criteria (greater than or equal to 2 prick tests with weal diameter greater than or equal to histamine control; or weal diameter 2 mm or more greater than a saline control), no significant association was demonstrated. Furthermore, linear logistic regression and multiple regression analyses showed that both the presence and the degree of NSBR were influenced much more by the baseline level of FEV1 than by atopic status. At best, atopy accounted for 10% of the variance of the PD20 measurements. We conclude that atopy is associated with NSBR but not strongly; that the relationship may be readily obscured according to the defining criteria used for atopy; and that atopy should not be used as a marker for NSBR.
Chest Unit, Newcastle General Hospital, University of Newcastle upon Tyne, U.K.
D N
DN
Grainger
S C
SC
Stenton
A J
AJ
Avery
M
M
Duddridge
E H
EH
Walters
D J
DJ
Hendrick
D000293:Adolescent; D000328:Adult; D001249:Asthma / Q000150:complications* / Q000175:diagnosis / Q000503:physiopathology; D001980:Bronchi / Q000187:drug effects / Q000276:immunology* / Q000503:physiopathology; D001985:Bronchial Provocation Tests; D004804:Eosinophils; D005541:Forced Expiratory Volume; D006801:Humans; D006969:Hypersensitivity, Immediate / Q000150:complications* / Q000175:diagnosis / Q000503:physiopathology; D007958:Leukocyte Count; D016210:Methacholine Chloride; D008688:Methacholine Compounds / Q000494:pharmacology
D008688:Methacholine Compounds; D016210:Methacholine Chloride